LON:DPH Dechra Pharmaceuticals (DPH) Share Price, News & Analysis → No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (From Hedgeye) (Ad) Free DPH Stock Alerts GBX 3,866 0.00 (0.00%) (As of 01/16/2024) Add Compare Share Share Today's Range 3,866▼ 3,86650-Day Range 3,866▼ 3,86652-Week Range 2,473.32▼ 4,145.84Volume2.04 million shsAverage Volume1.29 million shsMarket Capitalization£4.40 billionP/E RatioN/ADividend Yield1.16%Price TargetN/A Stock AnalysisStock AnalysisChartDividendHeadlinesInsider TradesStock AnalysisChartDividendHeadlinesInsider Trades Get Dechra Pharmaceuticals alerts: Email Address Ad Daily Market AlertsTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution…Click below for your free report "Top 5 Tech Stocks to Buy in 2024", About Dechra Pharmaceuticals Stock (LON:DPH)Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, internal medicine, and nutrition products supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. It also provides water soluble antibiotics, vaccines, lameness, pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. In addition, the company distributes veterinary pharmaceuticals and equipment; markets pet diets; and develops, regulates, manufactures, and markets crop protection, as well as offers financial services. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.Read More DPH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DPH Stock News HeadlinesFebruary 15, 2024 | finance.yahoo.comDechra Pharmaceuticals PLC (DPH.L)February 11, 2024 | benzinga.comDechra Pharmaceuticals Stock (OTC:DPHAY) Dividends: History, Yield and DatesJanuary 15, 2024 | finance.yahoo.comForm 8.3 - Dechra Phartmaceuticals PLC - AmendmentNovember 29, 2023 | msn.comUK's Hargreaves says Dechra's Platt to succeed Oppenheimer as chairNovember 10, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 09-November-23 Decrease in Traded Position DisclosureNovember 9, 2023 | morningstar.comDechra Pharmaceuticals PLC DPHNovember 2, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 01-November-23 Decrease in Traded Position DisclosureOctober 31, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 30-October-23 Decrease in Traded Position DisclosureOctober 30, 2023 | finanznachrichten.deMagnetar Capital Partners LP - Form 8.3 - Dechra Pharmaceuticals plcOctober 24, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 23-October-23 Increase in Traded Position DisclosureOctober 18, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 17-October-23 Increase in Traded Position DisclosureOctober 12, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 28-September-23 Increase in Traded Position AmendmentOctober 12, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 03-October-23 Decrease in Traded Position AmendmentOctober 12, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 05-October-23 Dealing Disclosure - AmendmentOctober 11, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 10-October-23 Decrease in Traded Position DisclosureOctober 4, 2023 | proactiveinvestors.comPrivate equity ‘vultures’ feast on beleaguered public marketsSeptember 29, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 28-September-23 Dealing DisclosureSeptember 21, 2023 | marketwatch.comDechra Pharmaceuticals falls Thursday, still outperforms marketSeptember 20, 2023 | finance.yahoo.comForm 8.3 - Dechra Pharmaceuticals plc - AmendmentSeptember 15, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 14-September-23 Dealing DisclosureAugust 31, 2023 | markets.businessinsider.comBack in the Big League: M&S Rejoins the FTSE 100 on Share Price BoostAugust 22, 2023 | finance.yahoo.comMarks & Spencer Set for FTSE 100 Comeback After This Year’s 78% Share Price RiseAugust 15, 2023 | marketwatch.comDechra Pharmaceuticals remains steady Tuesday, still outperforms marketJuly 20, 2023 | bloomberg.comDPH: Carlson Capital, L.P.: Form 8.3 - Dechra Pharmaceuticals plcJuly 12, 2023 | finance.yahoo.comForm 8.3 - DPH LN Equity 11-July-23 Increase in Traded PositionSee More Headlines Receive DPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dechra Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - General Sub-IndustryN/A Current SymbolLON:DPH CUSIPN/A CIKN/A Webwww.dechra.com Phone+44-1606-814730FaxN/AEmployees2,457Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.25) Trailing P/E RatioN/A Forward P/E Ratio20.41 P/E Growth1.42Net Income£-27,900,000.00 Net Margins-3.66% Pretax MarginN/A Return on Equity-3.92% Return on Assets0.75% Debt Debt-to-Equity Ratio66.80 Current Ratio2.85 Quick Ratio1.66 Sales & Book Value Annual Sales£761.50 million Price / Sales5.78 Cash FlowGBX 158.24 per share Price / Cash Flow24.43 Book ValueGBX 663 per share Price / Book5.83Miscellaneous Outstanding Shares113,910,000Free FloatN/AMarket Cap£4.40 billion OptionableNot Optionable Beta0.78 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Ian D. Page (Age 63)CEO, MD & Executive Director Comp: $848kMr. Paul Nicholas Sandland MAAT (Age 45)FCCA, CFO & Executive Director Comp: $559kMr. Patrick MeeusChief Scientific OfficerMr. Jamie AdamsChief Information OfficerMs. Katy CloughChief People OfficerMr. Mike Eldred (Age 54)President of North America Ms. Melanie Jane HallCompany SecretaryMore ExecutivesKey CompetitorsGSKLON:GSKSmith & NephewLON:SNConvaTec GroupLON:CTECHikma PharmaceuticalsLON:HIKMediclinic InternationalLON:MDCView All CompetitorsInsidersIan PageBought 155 shares on 1/15/2024Total: £501,735.00 ($3,237.00/share)View All Insider Transactions DPH Stock Analysis - Frequently Asked Questions How have DPH shares performed in 2024? Dechra Pharmaceuticals' stock was trading at GBX 3,858 at the start of the year. Since then, DPH stock has increased by 0.2% and is now trading at GBX 3,866. View the best growth stocks for 2024 here. Is Dechra Pharmaceuticals a good dividend stock? Dechra Pharmaceuticals (LON:DPH) pays an annual dividend of GBX 45 per share and currently has a dividend yield of 1.20%. Read our dividend analysis for DPH. What other stocks do shareholders of Dechra Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Dechra Pharmaceuticals investors own include 32Red (TTR), 1428686 (SGP.L) (SGP), JD Sports Fashion (JD), Ashtead Group (AHT), Cranswick (CWK), Drax Group (DRX), RPC Group (RPC), Robert Walters (RWA), SEB (SKP) and Barratt Developments (BDEV). How do I buy shares of Dechra Pharmaceuticals? Shares of DPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:DPH) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredWarren Buffett & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dechra Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Dechra Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.